These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells. Liu H; Pan Z; Li A; Fu S; Lei Y; Sun H; Wu M; Zhou W Cell Mol Immunol; 2008 Oct; 5(5):373-8. PubMed ID: 18954561 [TBL] [Abstract][Full Text] [Related]
5. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Schimanski CC; Schwald S; Simiantonaki N; Jayasinghe C; Gönner U; Wilsberg V; Junginger T; Berger MR; Galle PR; Moehler M Clin Cancer Res; 2005 Mar; 11(5):1743-50. PubMed ID: 15755995 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma. Li W; Gomez E; Zhang Z J Exp Clin Cancer Res; 2007 Dec; 26(4):527-33. PubMed ID: 18365549 [TBL] [Abstract][Full Text] [Related]
7. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma. Chen GS; Yu HS; Lan CC; Chow KC; Lin TY; Kok LF; Lu MP; Liu CH; Wu MT Br J Dermatol; 2006 May; 154(5):910-8. PubMed ID: 16634895 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573 [TBL] [Abstract][Full Text] [Related]
10. Functional expression of CXC chemokine recepter-4 mediates the secretion of matrix metalloproteinases from mouse hepatocarcinoma cell lines with different lymphatic metastasis ability. Chu H; Zhou H; Liu Y; Liu X; Hu Y; Zhang J Int J Biochem Cell Biol; 2007; 39(1):197-205. PubMed ID: 16973405 [TBL] [Abstract][Full Text] [Related]
11. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor. Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346 [TBL] [Abstract][Full Text] [Related]
12. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer. Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483 [TBL] [Abstract][Full Text] [Related]
13. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma. Hu F; Miao L; Zhao Y; Xiao YY; Xu Q Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228 [TBL] [Abstract][Full Text] [Related]
14. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Jiang YP; Wu XH; Shi B; Wu WX; Yin GR Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235 [TBL] [Abstract][Full Text] [Related]
15. Overactivation of the TGF-β pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells. Bertran E; Crosas-Molist E; Sancho P; Caja L; Lopez-Luque J; Navarro E; Egea G; Lastra R; Serrano T; Ramos E; Fabregat I Hepatology; 2013 Dec; 58(6):2032-44. PubMed ID: 23813475 [TBL] [Abstract][Full Text] [Related]
16. Role of CXCL12 in metastasis of human ovarian cancer. Jiang YP; Wu XH; Xing HY; DU XY Chin Med J (Engl); 2007 Jul; 120(14):1251-5. PubMed ID: 17697577 [TBL] [Abstract][Full Text] [Related]
17. [Nuclear accumulation of CXCR4 and overexpressions of VEGF-C and CK19 are associated with a higher risk of lymph node metastasis in hepatocellular carcinoma]. Xiang ZL; Zeng ZC; Tang ZY; Fan J; Sun HC; Wu WZ; Tan YS Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):344-9. PubMed ID: 20723431 [TBL] [Abstract][Full Text] [Related]
18. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases. Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975 [TBL] [Abstract][Full Text] [Related]
19. Regional expression of CXCL12/CXCR4 in liver and hepatocellular carcinoma and cell-cycle variation during in vitro differentiation. Shibuta K; Mori M; Shimoda K; Inoue H; Mitra P; Barnard GF Jpn J Cancer Res; 2002 Jul; 93(7):789-97. PubMed ID: 12149145 [TBL] [Abstract][Full Text] [Related]
20. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]